SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001183740-12-000308
Filing Date
2012-05-15
Accepted
2012-05-15 16:58:33
Documents
3
Period of Report
2012-05-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 f8k.htm 8-K 10663
2 LOAN CONTRACT ex10-1.htm EX-10.1 66917
3 PRESS RELEASE ex99-1.htm EX-99.1 3857
  Complete submission text file 0001183740-12-000308.txt   83014
Mailing Address 55 UBI AVE, #03-01 MINTWELL BUILDING U0 408864
Business Address 55 UBI AVE, #03-01 MINTWELL BUILDING U0 408864 65-6747-7883
Hubei Minkang Pharmaceutical Ltd. (Filer) CIK: 0001375850 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53231 | Film No.: 12845700
SIC: 2834 Pharmaceutical Preparations